Pradžia › Virškinimo ligos › Mičiganas
Virškinimo ligos klinikiniai tyrimai Mičiganas
6 tyrimai dėl Virškinimo ligos ieško dalyvių vietose Mičiganas.
Miestai Mičiganas
Oficialus tyrimo tekstas (anglų kalba)
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
- University of Michigan Health, Ann Arbor
- Henry Ford, Detroit
Renkami dalyviai
Amžius nuo 65 iki 82 · Visoms lytims · Atnaujinta 2026-10-02 · NCT05612347A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Western Michigan, P.L.C., Wyoming
Renkami dalyviai2 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-30 · NCT06598943Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- The Cancer & Hematology Centers, Big Rapids
- The Cancer & Hematology Centers, Grand Rapids
- The Cancer & Hematology Centers, Grand Rapids
- ir dar 2
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-09-28 · NCT07222800Product Surveillance Registry
- Ann Arbor
- Bay City
- Lansing
- ir dar 2
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-09-18 · NCT01524276A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
- 89bio Clinical Study Site, Chesterfield
- 89bio Clinical Study Site, Wyoming
- 89bio Clinical Study Site, Ypsilanti
Renkami dalyviai3 fazė
Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06318169A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
- 89bio Clinical Study Site, Ann Arbor
- 89bio Clinical Study Site, Clinton Township
- 89bio Clinical Study Site, Detroit
- ir dar 2
Renkami dalyviai3 fazė
Amžius nuo 18 iki 75 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06419374Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.